Skip to main content
. 2017 Sep 15;108(11):2295–2305. doi: 10.1111/cas.13379

Table 1.

Summary of the human angiosarcoma clinical cases assayed

Case Gender Age Site Size (mm) Nodal metastasis Distant metastasis Recurrence Chemotherapy Radiotherapy Outcome Survivin YAP Hippo
A01 Male 82 Scalp 15 + + (lung) Stationary + (DTX) + (70 Gy) Death (7 months) 2 0
A02 Male 61 Right forehead 10 Stationary + (DTX) + (70 Gy) Alive (24 months) 2 0
A03 Male 89 Scalp 15 + (lung) Unknown + (70 Gy) Death (7 months) 2 0
A04 Male 88 Left forehead‐calvaria 15 + + (bone) Stationary + (70 Gy) Death (27 months) 2 0
A05 Male 73 Calvaria 30 + (lung, parotid gland) + + (DTX) + (60 Gy) Death (60 months) 3 1 (N+cyto) OFF
A06 Female 91 Forehead‐calvaria 200 + (70 Gy) Death (11 months) 2 2 (N) OFF
A07 Female 78 Calvaria 30 + (DTX) + (70 Gy) Death (6 months) 3 2 (N+cyto) OFF
A08 Female 57 Left forehead 60 + (DTX) + (70 Gy) Alive (38 months) 3 2 (N+cyto) OFF
A09 Female 67 Left temple 40 + (DTX) + (70 Gy) Alive (38 months) 2 0
A10 Female 73 Calvaria 50 + (lung) Stationary + (70 Gy) Death (6 months) 1 1 (N) OFF
A11 Male 80 Scalp 60 + (lung) + (DTX) + (70 Gy) Death (8 months) 2 1 (N) OFF
A12 Female 80 Right chest Unknown Unknown Unknown Unknown Unknown Unknown Unknown 3 3 (N+cyto) OFF
A13 Male 63 Left forehead 30 + (lung) + (DTX) + (70 Gy) Death (9 months) 2 2 (N) OFF
A14 Male 85 Calvaria‐occiput 20 + + (lung, parotid gland) + + (70 Gy) Death (25 months) 3 3 (N+cyto) OFF
A15 Male 64 Right submandibular 10 + + (lung, liver) + + (DTX) + (70 Gy) Death (45 months) 3 2 (N+cyto) OFF
A16 Male 74 Right forehead 30 + + (lung, parotid gland, bone) + + (70 Gy) Death (21 months) 3 3 (N+cyto) OFF
A17 Male 73 Calvaria 39 + (lung, liver, adrenal gland, bone) + + (DTX) + (60 Gy) Death (21 months) 1 1 (N) OFF
A18 Female 92 Right cheek 34 Unknown + (lung) + + (60 Gy) Death (15 months) 2 1 (N) OFF
A19 Female 73 Left calvaria 25 Unknown + (lung) unknown + (DTX) Death (9 months) 2 2 (N+cyto) OFF
A20 Male 79 Left temple 50 + + (lung, liver) stationary Death (10 months) 2 2 (N+cyto) OFF
A21 Male 73 Calvaria 35 Unknown unknown stationary Unknown 2 2 (cyto) ON
A22 Female 81 Calvaria 80 stationary + (20 Gy) Death (2 months) 2 2 (N+cyto) OFF
A23 Male 85 Occiput 20 + (lung) + + (178 Gy) Death (82 months) 2 0
A24 Male 78 Calvaria 26 Unknown + (lung) + + (70 Gy) Death (17 months) 3 3 (N+cyto) OFF
A25 Male 85 Calvaria 40 + + (lung) Unknown + (60 Gy) Death (14 months) 3 2 (N+cyto) OFF
A26 Male 75 Calvaria 37 Unknown + (lung, liver, spleen) Unknown + (DTX) + (60 Gy) Death (4 months) 3 3 (N+cyto) OFF
A27 Male 75 Calvaria 24 + (lung, liver, spleen) Unknown Death (11 months) 2 2 (N) OFF
A28 Female 87 Calvaria 30 Unknown + (lung) Unknown + (DTX) Death (3 months) 3 1 (cyto) ON
A29 Male 75 Forehead 150 + (lung) + + (DTX) + (70 Gy) Death (26 months) 2 1 (cyto) ON
A30 Female 78 Calvaria 120 Unknown + (lung, bone) + + (DTX) + (70 Gy) Death (21 months) 2 2 (N) OFF
A31 Female 75 Posterior auricle 50 + (parotid gland) + + (DTX) + (70 Gy) Death (92 months) 2 2 (N+cyto) OFF
A32 Male 58 Posterior auricle 50 Unknown + (lung) Unknown + (DTX) + (70 Gy) Death (49 months) 2 3 (N+cyto) OFF
A33 Male 74 Forehead 140 + (lung) Stationary + (60 Gy) Death (9 months) 3 3 (cyto) ON
A34 Female 93 Calvaria 32 + + + (60 Gy) Death (13 months) 3 2 (N) OFF
A35 Male 81 Calvaria 30 + + (lung) Stationary + (7 Gy) Death (5 months) 3 2 (N+cyto) OFF
A36 Female 96 Calvaria 30 Unknown + (70 Gy) Unknown 3 3 (cyto) ON
A37 Male 76 Calvaria 15 + (spleen) Stationary + (DTX) + (70 Gy) Death (22 months) 2 0
A38 Male 86 Forehead 20 Stationary + (DTX) + (70 Gy) Unknown 2 0
A39 Male 75 Scalp 60 + (lung) + (DTX) + (70 Gy) Death (11 months) 2 0
A40 Male 75 Forehead 20 + + (DTX) Death (17 months) 2 0
A41 Female 86 Forehead 70 Unknown unknown Unknown unknown unknown Death (19 months) 1 2 (N) OFF
A42 Male 71 Calvaria 35 + (lung, small intestine) Unknown + (28 Gy) Death (10 months) 2 3 (N+cyto) OFF
A43 Male 70 Forehead 150 + (lung, bone) Stationary + (DTX) + (60 Gy) Death (4 months) 1 2 (N) OFF
A44 Male 75 Forehead 143 + + (lung) + + (DTX) + (60 Gy) Death (16 months) 1 2 (N+cyto) OFF
A45 Male 78 Calvaria 15 + (lung) + + (DTX) + (70 Gy) Death (16 months) 1 2 (N) OFF
A46 Male 78 Forehead 80 + (lung, liver) Stationary + (DTX) + (70 Gy) Death (7 months) 1 1 (N) OFF
A47 Male 59 Scalp 20 Alive 1 1 (cyto) ON
A48 Male 65 Neck 29 + + (liver) + Alive 1 1 (N) OFF
A49 Male 60 Scalp 210 Alive 3 2 (N) OFF
A50 Male 78 Face Unknown + + Alive 3 0
A51 Male 71 Occiput 40 + + (50 Gy) Alive 3 2 (N+cyto) OFF
A52 Male 80 Forehead 100 + + (lung, liver) + + (60 Gy) Death (15 months) 3 1 (N) OFF
A53 Male 79 Face Unknown Stationary Death (6 months) 3 2 (N+cyto) OFF
A54 Male 75 Left temple‐neck Unknown + + (lung) Stationary + (DTX) + Death (2 months) 3 0
A55 Female 87 Left forehead 80 Unknown + (lung, bone) Stationary + (DTX) + (60 Gy) Death (6 months) 1 1 (N) OFF
A56 Male 63 Left temple 25 + + (DTX) + Alive 1 2 (N) OFF
A57 Male 76 Occiput 35 + (lung) Stationary + (DTX) + Death (18 months) 2 1 (N) OFF
A58 Male 87 Left forehead 60 + Alive 2 1 (N) OFF
A59 Female 62 Scalp 25 + (lung, femur) + Death (6 months) 2 1 (N) OFF
A60 Male 82 Scalp 165 Alive 2 1 (N+cyto) OFF
A61 Male 66 Left forehead 100 + + (DTX) Alive 3 3 (N+cyto) OFF
A62 Male 77 Forehead 40 + + (DTX) + alive 2 1 (N+cyto) OFF
A63 Male 77 Left calvaria 60 + + (DTX) + Alive 3 2 (N) OFF
A64 Male 76 Calvaria 220 + (bone) + + (DTX) + Death (24 months) 3 2 (N+cyto) OFF
A65 Male 77 Right calvaria 100 + + (lung) + + (DTX) + Death (36 months) 3 0
A66 Male 60 Left calvaria 50 + Stationary + (DTX) + Death (18 months) 3 2 (N) OFF
A67 Male 72 Left calvaria 37 + + (DTX) + Death (48 months) 2 2 (N) OFF
A68 Female 50 Occiput 22 + + (lung, bone, pancreas, peritoneum) + + (DTX) + Death (48 months) 3 1 (N) OFF
A69 Male 86 Calvaria 80 + (DTX) + Alive 2 2 (N+cyto) OFF
A70 Female 61 Left temple 37 + (bone, liver) + + (DTX) + Death (24 months) 3 1 (N) OFF
A71 Female 64 Left temple 40 + Stationary + (DTX) + Alive 3 2 (N+cyto) OFF
A72 Female 62 Scalp 20 Alive 3 1 (N) OFF
A73 Female 63 Calvaria 20 + + Alive 3 1 (N+cyto) OFF
A74 Male 80 Calvaria 40 + + (DTX) + Alive 3 1 (N+cyto) OFF
A75 Male 74 Left forehead 90 + (bone) Stationary + (DTX) + Death (12 months) 2 1 (N+cyto) OFF
A76 Female 74 Chest 90 + (liver) + + Death 2 3 (N+cyto) OFF
A77 Female 55 Forearm 15 Unknown + Death 1 1 (N) OFF
A78 Female 67 Groin 67 + + (lung, peritoneal cavity, intestine) + + (DTX) Death 2 2 (N+cyto) OFF
A79 Female 70 Foot 12 + + (scalp, retroperitoneum) + Death 3 2 (N+cyto) OFF
A80 Female 64 Lower leg 10 + + (femur) Death 2 2 (N+cyto) OFF
A81 Male 61 Unknown 61 + (bone) + (wPTX) Unknown 2 2 (cyto) ON
A82 Female 36 Dorsal skin 42 + (bone) + Alive 3 3 (N+cyto) OFF
A83 Female 42 Femur 35 Alive 2 2 (N+cyto) OFF
A84 Male 77 Shoulder 85 + + (scalp) + + Death 3 3 (N+cyto) OFF
A85 Male 16 Lower leg 20 + + (femur, skin) + + (DXR) + Death 3 1 (N) OFF

DTX, docetaxel; DXR, doxorubicin (Adriamycin); outcome, months after diagnosed; survivin, nuclear positivity; YAP, nuclear (N) and cytoplasmic (cyto) positivity; wPTX, weekly paclitaxel. Score 0 (no staining), 1 (faint/barely staining in tumor cells), 2 (weak to moderate staining in 10–50% of the tumor cells) or 3 (uniform intense staining in over 50% of the tumor cells).